BRIDGEWAY CAPITAL MANAGEMENT, LLC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 71 filers reported holding REGENXBIO INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of REGENXBIO INC
ValueSharesWeighting
Q1 2023$3,756,093
-2.5%
198,630
+16.9%
0.10%0.0%
Q4 2022$3,853,332
-14.2%
169,9000.0%0.10%
-16.7%
Q3 2022$4,490,000
+25.5%
169,900
+17.3%
0.12%
+46.3%
Q2 2022$3,579,000
+550.7%
144,900
+420.2%
0.08%
+1071.4%
Q2 2017$550,000
+2.2%
27,8520.0%0.01%0.0%
Q1 2017$538,000
+4.1%
27,8520.0%0.01%0.0%
Q4 2016$517,000
-43.1%
27,852
-57.1%
0.01%
-50.0%
Q3 2016$909,00064,8520.01%
Other shareholders
REGENXBIO INC shareholders Q3 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders